Pharmacological inhibition of the mitochondrial NADPH oxidase 4/PKC/Gal-3 signaling pathway attenuates adverse cardiac fibrosis, following myocardial infarction

Category Primary study
JournalEuropean Heart Journal
Year 2018
This article has no abstract
Epistemonikos ID: 83fe743f9280303a838a75d82771ed37fb7edfeb
First added on: Feb 10, 2025